HP
BCYC

HealthInvest Partners’s Bicycle Therapeutics BCYC Stock Holding History

HealthInvest Partners’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$6.69K Buy
+226
New +$6.06K 0.01% 46

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

HealthInvest Partners's BCYC Position: Q4 2022 in Review

HealthInvest Partners opened a new position in Bicycle Therapeutics (BCYC) in Q4 2022: 226 shares worth $6.69K. The stake represents 0.01% of the portfolio and ranks #46 among its holdings.

87 funds tracked by Wall St. Rank hold BCYC as of Q4 2022.

  • HealthInvest Partners held 226 shares of Bicycle Therapeutics worth $6.69K as of Q4 2022.
  • Bicycle Therapeutics was a new HealthInvest Partners position in Q4 2022.
  • Bicycle Therapeutics made up 0.01% of HealthInvest Partners's portfolio in Q4 2022, its #46 holding.
  • 87 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.